Author: Andrew Powrie-Smith Date: 05/04/2016 Version: draft

The biopharmaceutical industry generates essential economic value in terms of job creation, R&D investment, and medications that improve patient productivity
With over 7000 medicines in development, the exciting new wave of medical innovation will play a key role in
addressing the challenges faced by patients and healthcare systems
Source: Health Advances analysis; Adis R&D Insight Database. March 2015, compiled by PhRMA

Patients all over the Europe are living longer, healthier and more productive lives thanks to innovative medicines developed by biopharmaceutical companies.

Patients all over the Europe are living longer, healthier and more productive lives thanks to innovative medicines developed by biopharmaceutical companies.

Value to patients

For many patients and their families

For many patients and their families

Medicines have significantly increased chances of survival

Cancer
New therapies have contributed to significant declines in cancer death rates around the world since its peak in 1991. Today, 2 out of 3 people diagnosed with cancer survive at least 5 years1.
Percent Decline in Cancer Mortality Rates Since 1991
1991 to 2011 - All Cancers2
Source: Health Advances analysis; 1PhRMA 2016 Prescription Medicines: Costs in Context; 2WHO Mortality Database (accessed February 2016).
EU5
Australia
South Korea
Japan
Canada
Mexico
-21%
-8%
-21%
-22%
-17%
-15%
USA
-24%

For cancer patients, Life expectancy continues to improve the use of innovative medicines has made major contribution to recent advances

For cancer patients, Life expectancy continues to improve the use of innovative medicines has made major contribution to recent advances